Table 2.
p16 | HPV DNA genotype | Subsite | SEER stage | Histology | Grade | Gender | Age group |
---|---|---|---|---|---|---|---|
Positive | 18 | Glottis | Localized | SCC non-keratinizing | 2 | Male | 40–49 |
Positive | 35, 89 | Glottis | Localized | SCC papillary | 1 | Male | 40–49 |
Negative | 16 | Supraglottis | Regional | SCC non-keratinizing | 2 | Female | 80–89 |
Negative | 35 | Glottis | Localized | SCC papillary | 1 | Female | 70–79 |
Negative | 39 | Supraglottis | Regional | SCC keratinizing | 2 | Female | 50–59 |
Negative | 16, 54 | Supraglottis | Regional | SCC keratinizing | 3 | Male | 70–74 |
Negative | 18, 33 | Glottis | Distant | SCC keratinizing | 2 | Male | 65–69 |
Negative | 16 | Supraglottis | Localized | SCC keratinizing | 2 | Male | 65–69 |
Negative | 11 | Supraglottis | Distant | SCC NOS | 3 | Female | 55–59 |
Negative | Untyped | Glottis | Localized | SCC verrucous | a | Male | 65–69 |
Negative | 16 | Supraglottis | Regional | SCC keratinizing | 3 | Male | 70–74 |
Negative | 33 | Supraglottis | Regional | SCC keratinizing | 2 | Female | 55–59 |
Negative | 16, 31, 33 | Glottis | Localized | SCC keratinizing | 2 | Male | 45–49 |
Negative | 51 | Supraglottis | Regional | SCC non-keratinizing | 3 | Male | 75–79 |
Negative | 51 | Glottis | Localized | SCC keratinizing | 2 | Male | 60–64 |
Negative | 6 | Glottis | Regional | SCC non-keratinizing | 2 | Female | 50–54 |
Tumor grade could not be ascertained based on the registry data and secondary pathologic review.